These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32349553)

  • 41. Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review.
    Nair AT; Ramachandran V; Joghee NM; Antony S; Ramalingam G
    J Neurogastroenterol Motil; 2018 Jan; 24(1):30-42. PubMed ID: 29291606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An overview of the neuroendocrine system in Parkinson's disease: what is the impact on diagnosis and treatment?
    Mulak A
    Expert Rev Neurother; 2020 Feb; 20(2):127-135. PubMed ID: 31829756
    [No Abstract]   [Full Text] [Related]  

  • 43. Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson's Disease.
    Hegelmaier T; Lebbing M; Duscha A; Tomaske L; Tönges L; Holm JB; Bjørn Nielsen H; Gatermann SG; Przuntek H; Haghikia A
    Cells; 2020 Feb; 9(2):. PubMed ID: 32041265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A role of the gastrointestinal tract microbiota in the pathogenesis of Parkinson's disease].
    Alifirova VM; Zhukova NG; Zhukova IA; Latypova AV; Titova MA; Mironova YS; Izhboldina OP; Nikitina MA; Petrov VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):174-179. PubMed ID: 28635757
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.
    Hill-Burns EM; Debelius JW; Morton JT; Wissemann WT; Lewis MR; Wallen ZD; Peddada SD; Factor SA; Molho E; Zabetian CP; Knight R; Payami H
    Mov Disord; 2017 May; 32(5):739-749. PubMed ID: 28195358
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nutrition and Gut-Brain Pathways Impacting the Onset of Parkinson's Disease.
    Terenzi D; Muth AK; Park SQ
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Actions of Trace Amines in the Brain-Gut-Microbiome Axis via Trace Amine-Associated Receptor-1 (TAAR1).
    Bugda Gwilt K; González DP; Olliffe N; Oller H; Hoffing R; Puzan M; El Aidy S; Miller GM
    Cell Mol Neurobiol; 2020 Mar; 40(2):191-201. PubMed ID: 31836967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Positive effect of an electrolyzed reduced water on gut permeability, fecal microbiota and liver in an animal model of Parkinson's disease.
    Bordoni L; Gabbianelli R; Fedeli D; Fiorini D; Bergheim I; Jin CJ; Marinelli L; Di Stefano A; Nasuti C
    PLoS One; 2019; 14(10):e0223238. PubMed ID: 31600256
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Gut and Parkinson's Disease: Hype or Hope?
    Scheperjans F; Derkinderen P; Borghammer P
    J Parkinsons Dis; 2018; 8(s1):S31-S39. PubMed ID: 30584161
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The roles of gut-brain interaction in models of Parkinson's disease].
    Kitaoka S
    Nihon Yakurigaku Zasshi; 2020; 155(5):352. PubMed ID: 32879179
    [No Abstract]   [Full Text] [Related]  

  • 51. [The role of the gut microbiome in idiopathic Parkinson's disease].
    Unger MM; Becker A; Keller A; Schäfer KH; Schwiertz A; Oertel WH
    Nervenarzt; 2020 Dec; 91(12):1085-1095. PubMed ID: 33025073
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gut-initiated neuroprotection in Parkinson's disease: When microbes turn the tables in the battle against neuroinflammation.
    Barros-Santos T; Clarke G
    Brain Behav Immun; 2023 Feb; 108():350-352. PubMed ID: 36549579
    [No Abstract]   [Full Text] [Related]  

  • 53. Minireview on the Relations between Gut Microflora and Parkinson's Disease: Further Biochemical (Oxidative Stress), Inflammatory, and Neurological Particularities.
    Ilie OD; Ciobica A; McKenna J; Doroftei B; Mavroudis I
    Oxid Med Cell Longev; 2020; 2020():4518023. PubMed ID: 32089768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features.
    Li W; Wu X; Hu X; Wang T; Liang S; Duan Y; Jin F; Qin B
    Sci China Life Sci; 2017 Nov; 60(11):1223-1233. PubMed ID: 28536926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gut, Microbiome, and Brain Regulatory Axis: Relevance to Neurodegenerative and Psychiatric Disorders.
    Stefano GB; Pilonis N; Ptacek R; Raboch J; Vnukova M; Kream RM
    Cell Mol Neurobiol; 2018 Aug; 38(6):1197-1206. PubMed ID: 29802603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Probiotics for Parkinson's Disease.
    Gazerani P
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450864
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway.
    Kim DS; Choi HI; Wang Y; Luo Y; Hoffer BJ; Greig NH
    Cell Transplant; 2017 Sep; 26(9):1560-1571. PubMed ID: 29113464
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gut Microbiome Imbalance and Neuroinflammation: Impact of COVID-19 on Parkinson's Disease.
    Follmer C
    Mov Disord; 2020 Sep; 35(9):1495-1496. PubMed ID: 32822087
    [No Abstract]   [Full Text] [Related]  

  • 59. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
    Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
    J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lots of Movement in Gut and Parkinson's Research.
    Mercado G; Brundin P
    Trends Endocrinol Metab; 2019 Oct; 30(10):687-689. PubMed ID: 31473011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.